Forty five percent of the Israeli population were infected with the influenza B Victoria virus during the winter season 2015-16

Oncotarget

Volumn 9, Issue 5, 2018, Pages 6623-6629

  Sharabi, Sivan ^a,b   Bassal, Ravit ^a   Friedman, Nehemya ^a,b   Drori, Yaron ^a,b   Alter, Hadar ^a   Glatman Freedman, Aharona ^a,b,c   Hindiyeh, Musa ^a,b   Cohen, Daniel ^b   Mendelson, Ella ^a,b   Shohat, Tamy ^a,b   Mandelboim, Michal ^a,b  

^a MINISTRY OF HEALTH   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Influenza B; Vaccine; Victoria; Yamagata

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; CHILD; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFANT; INFLUENZA B; INFLUENZA B VICTORIA VIRUS; INFLUENZA B VIRUS; INFLUENZA B YAMAGATA VIRUS; ISRAEL; MAJOR CLINICAL STUDY; NONHUMAN; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERY ELDERLY; VIRUS STRAIN; WINTER;

EID: 85040640735     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.23601     Document Type: Article

References (31)

1. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003; 362:1733-1745
2. Wright PNG, Kawaoka Y. Orthomyxoviruses. In Fields Virology. 2006; 5th edition:1691-1740
3. Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012; 8:81-88
4. Neumann G, Noda T, Kawaoka Y. Emergence, pandemic potential of swine-origin H1N1 influenza virus. Nature. 2009; 459:931-939
5. Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine. 1999; 17:S3-10
6. Cromer D, van Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E. The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Infect. 2014; 68:363-371
7. Saitou N, Nei M. Polymorphism and evolution of influenza A virus genes. Mol Biol Evol. 1986; 3:57-74
8. Webster RG, Hinshaw VS, Bean WJ Jr. Antigenic shift in myxoviruses. Med Microbiol Immunol. 1977; 164:57-68
9. Kanegae Y, Sugita S, Endo A, Ishida M, Senya S, Osako K, Nerome K, Oya A. Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: cocirculating lineages in the same epidemic season. J Virol. 1990; 64:2860-2865
10. Nelson MI, Simonsen L, Viboud C, Miller MA, Taylor J, George KS, Griesemer SB, Ghedin E, Sengamalay NA, Spiro DJ, Volkov I, Grenfell BT, Lipman DJ, et al. Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog. 2006; 2:e125
11. Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology. 1990; 175:59-68
12. Chi XS, Hu A, Bolar TV, Al-Rimawi W, Zhao P, Tam JS, Rappaport R, Cheng SM. Detection and characterization of new influenza B virus variants in 2002. J Clin Microbiol. 2005; 43:2345-2349
13. Tewawong N, Suntronwong N, Korkong S, Theamboonlers A, Vongpunsawad S, Poovorawan Y. Evidence for influenza B virus lineage shifts and reassortants circulating in Thailand in 2014-2016. Infect Genet Evol. 2017; 47:35-40
14. Shaw MW, Xu X, Li Y, Normand S, Ueki RT, Kunimoto GY, Hall H, Klimov A, Cox NJ, Subbarao K. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology. 2002; 303:1-8
15. Caini S, Huang QS, Ciblak MA, Kusznierz G, Owen R, Wangchuk S, Henriques CM, Njouom R, Fasce RA, Yu H, Feng L, Zambon M, Clara AW, et al. Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study. Influenza Other Respir Viruses. 2015; 9:3-12
16. Turbelin C, Souty C, Pelat C, Hanslik T, Sarazin M, Blanchon T, Falchi A. Age distribution of influenza like illness cases during post-pandemic A(H3N2): comparison with the twelve previous seasons, in France. PLoS One. 2013; 8:e65919
17. Jennings Z, Carter I, McPhie K, Kok J, Dwyer DE. Increased prevalence of influenza B/Victoria lineage viruses during early stages of the 2015 influenza season in New South Wales, Australia: implications for vaccination and planning. Euro Surveill. 2015; 20
18. Organization WH. Recommended composition of influenza virus vaccine for use in the 2002-2003 influenza season. Wkly Epidemiol Rec. 2002; 77:57-68
19. Organization WH. Recommended composition of influenza virus vaccine for use inthe 2003-2004 influenza season. Wkly Epidemiol Rec. 2003; 77:341-344
20. Hsu SB, Hsieh YH. On the role of asymptomatic infection in transmission dynamics of infectious diseases. Bull Math Biol. 2008; 70:134-155
21. Hsieh YH, Tsai CA, Lin CY, Chen JH, King CC, Chao DY, Cheng KF. Asymptomatic ratio for seasonal H1N1 influenza infection among schoolchildren in Taiwan. BMC Infect Dis. 2014; 14:80
22. Langley JM, Carmona Martinez A, Chatterjee A, Halperin SA, McNeil S, Reisinger KS, Aggarwal N, Huang LM, Peng CT, Garcia-Sicilia J, Salamanca de la Cueva I, Cabanas F, Trevino-Garza C, et al. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children. J Infect Dis. 2013; 208:544-553
23. Skowronski DM, Hamelin ME, Janjua NZ, De Serres G, Gardy JL, Rheaume C, Bouhy X, Boivin G. Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance. PLoS One. 2012; 7:e38929
24. Skowronski DM, Hottes TS, De Serres G, Ward BJ, Janjua NZ, Sabaiduc S, Chan T, Petric M. Influenza Beta/Victoria antigen induces strong recall of Beta/Yamagata but lower Beta/Victoria response in children primed with two doses of Beta/Yamagata. Pediatr Infect Dis J. 2011; 30:833-839
25. Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine. 2012; 30:1993-1998
26. Akazawa M, Sindelar JL, Paltiel AD. Economic costs of influenza-related work absenteeism. Value Health. 2003; 6:107-115
27. Rahmqvist M, Gjessing K, Faresjo T. Influenza-related healthcare visits, hospital admissions, and direct medical costs for all children aged 2 to 17 years in a defined Swedish region, monitored for 7 years. Medicine (Baltimore). 2016; 95:e4599
28. Hindiyeh M, Levy V, Azar R, Varsano N, Regev L, Shalev Y, Grossman Z, Mendelson E. Evaluation of a multiplex real-time reverse transcriptase PCR assay for detection and differentiation of influenza viruses A and B during the 2001-2002 influenza season in Israel. J Clin Microbiol. 2005; 43:589-595
29. Meningher T, Hindiyeh M, Regev L, Sherbany H, Mendelson E, Mandelboim M. Relationships between A(H1N1)pdm09 influenza infection and infections with other respiratory viruses. Influenza Other Respir Viruses. 2014; 8:422-430
30. Biere B, Bauer B, Schweiger B. Differentiation of influenza B virus lineages Yamagata and Victoria by real-time PCR. J Clin Microbiol. 2010; 48:1425-1427
31. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, Fukuda K, Cox NJ, Katz JM. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol. 1999; 37:937-943